Liposomal Bupivacaine Nerve Block Possible ‘Game Changer’ in Shoulder Surgery
In a phase 3 trial designed to meet FDA standards for approval, investigators demonstrated that liposomal bupivacaine (Exparel, Pacira) administered as a single-injection nerve block significantly reduced pain and decreased or eliminated opioid consumption 48 hours after surgery in patients undergoing shoulder surgery.
